This dose–effect mismatch was observed by comparing clinical and pre-clinical studies, showing that doses of autologous GFs are capable of inducing positive effects in human skin ulcer healing (6 mm diameter) using autologous VEGF (8 ng) and PDGF (640 ng) within ABDPS [49]. Here, VEGFA is linked to Skin ulcer.